Immix Biopharma, Inc.IMMXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P55
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -14.06% |
| Q2 2025 | -43.45% |
| Q1 2025 | 6.10% |
| Q4 2024 | 32.56% |
| Q3 2024 | -57.26% |
| Q2 2024 | 15.88% |
| Q1 2024 | -3.99% |
| Q4 2023 | -18.83% |
| Q3 2023 | -21.58% |
| Q2 2023 | -47.60% |
| Q1 2023 | 33.57% |
| Q4 2022 | -147.47% |
| Q3 2022 | 1.77% |
| Q2 2022 | -17.36% |
| Q1 2022 | -122.29% |
| Q4 2021 | -71.94% |
| Q3 2021 | -43.11% |
| Q2 2021 | -49.62% |
| Q1 2021 | -5.81% |
| Q4 2020 | -68.34% |
| Q3 2020 | 12.71% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |